These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23077733)

  • 1. New ESC heart failure guidelines with South African expert comment.
    Aalbers J
    Cardiovasc J Afr; 2012 Jun; 23(5):295-6. PubMed ID: 23077733
    [No Abstract]   [Full Text] [Related]  

  • 2. [ Upgrading of cardiac resynchronization therapy devices in patients with heart failure--uprising clinical problem. ].
    Przybylski A
    Kardiol Pol; 2010 Nov; 68(11):1242. PubMed ID: 21108201
    [No Abstract]   [Full Text] [Related]  

  • 3. [European Society of Cardiology guidelines on cardiac resynchronization therapy].
    Robinet S; Delcour A; Lancellotti P;
    Rev Med Liege; 2014 Apr; 69(4):180-7. PubMed ID: 24923097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2012 ESC Guidelines on Heart Failure.
    Taylor J
    Eur Heart J; 2012 Jul; 33(14):1703-4. PubMed ID: 22797149
    [No Abstract]   [Full Text] [Related]  

  • 5. Heart rates in cardiac resynchronization: the art of optimal device programming.
    Maass AH; van Veldhuisen DJ
    Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
    [No Abstract]   [Full Text] [Related]  

  • 6. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
    Dickstein K; Vardas PE; Auricchio A; Daubert JC; Linde C; McMurray J; Ponikowski P; Priori SG; Sutton R; van Veldhuisen DJ;
    Eur Heart J; 2010 Nov; 31(21):2677-87. PubMed ID: 20801924
    [No Abstract]   [Full Text] [Related]  

  • 7. National Institute for Health and Care Excellence 2014 guidance on cardiac implantable electronic devices: health economics reloaded.
    Leyva F; Plummer CJ
    Europace; 2015 Mar; 17(3):339-42. PubMed ID: 25722476
    [No Abstract]   [Full Text] [Related]  

  • 8. New developments in cardiac resynchronization therapy.
    Sankaranarayanan R; Visweswariah R; Fox DJ
    Br J Hosp Med (Lond); 2013 Sep; 74(9):503-9. PubMed ID: 24022551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing atrioventricular and interventricular intervals following cardiac resynchronization therapy.
    Nayar V; Khan FZ; Pugh PJ
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):185-97. PubMed ID: 21453215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Resynchronization Therapy in Congestive Heart Failure Patients.
    Williams J
    Can J Cardiovasc Nurs; 2014; 24(3):3-5. PubMed ID: 27356459
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac resynchronization therapy for chronic heart failure in China: guideline and practice.
    Hua W
    Chin Med J (Engl); 2010 Sep; 123(17):2293-4. PubMed ID: 21034536
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac resynchronization therapy: an updateimpaired left ventricular systolic function.
    Garikipati NV; Schaefer MJ; Steinberg JS
    Minerva Cardioangiol; 2011 Feb; 59(1):89-100. PubMed ID: 21285934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Year in Cardiology 2012: heart failure.
    McDonagh TA
    Eur Heart J; 2013 Feb; 34(7):499-502. PubMed ID: 23321348
    [No Abstract]   [Full Text] [Related]  

  • 14. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
    Dickstein K; Vardas PE; Auricchio A; Daubert JC; Linde C; McMurray J; Ponikowski P; Priori SG; Sutton R; van Veldhuisen DJ;
    Europace; 2010 Nov; 12(11):1526-36. PubMed ID: 20974767
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of a tool combining guide-wire and stylet for the left ventricular lead positioning.
    Giannola G; Iacopino S; Lombardo E; Cesario A; Di Stefano G; Piraino LG; Campisi G; Torcivia R; Corrao D; Risi A; Denaro A; Valsecchi S;
    Europace; 2011 Feb; 13(2):244-50. PubMed ID: 21131651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute haemodynamic effects of increase in paced heart rate in heart failure patients recorded with an implantable haemodynamic monitor.
    Ståhlberg M; Kessels R; Linde C; Braunschweig F
    Europace; 2011 Feb; 13(2):237-43. PubMed ID: 20952424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiac resynchronization therapy in heart failure--Norwegian guidelines].
    Holm T; Færestrand S; Larsen AI; Jønland KB; Gullestad L; Dickstein K; Köpp U; Sirnes PA; Tande P; Steen T; Kongsgård E
    Tidsskr Nor Laegeforen; 2014 May; 134(10):E1-17. PubMed ID: 24865746
    [No Abstract]   [Full Text] [Related]  

  • 18. Coronary sinus atresia complicating cardiac resynchronization therapy.
    Nakamura T; Otomo K; Kawai S; Igawa O
    J Cardiovasc Electrophysiol; 2010 Oct; 21(10):1178. PubMed ID: 20522151
    [No Abstract]   [Full Text] [Related]  

  • 19. How to assess the nonresponder to cardiac resynchronization therapy-a comprehensive stepwise approach.
    Kutyifa V; Breithardt OA
    Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):504-10. PubMed ID: 22521484
    [No Abstract]   [Full Text] [Related]  

  • 20. [New Norwegian guidelines for resynchronization therapy in heart failure].
    Holm T; Kongsgård E
    Tidsskr Nor Laegeforen; 2014 Aug; 134(14):1346-7. PubMed ID: 25096427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.